These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21837444)

  • 1. Impact of HIV and aging on neuropsychological function.
    Wendelken LA; Valcour V
    J Neurovirol; 2012 Aug; 18(4):256-63. PubMed ID: 22528478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.
    Mind Exchange Working Group
    Clin Infect Dis; 2013 Apr; 56(7):1004-17. PubMed ID: 23175555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.
    Beardsley J; Le T
    Neurology; 2015 Feb; 84(6):632. PubMed ID: 25666633
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND.
    Petralia MC; Nicoletti F; Tancheva L; Kalfin R; Fagone P; Mangano K
    Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression patterns associated with neurological disease in human HIV infection.
    Sanna PP; Repunte-Canonigo V; Masliah E; Lefebvre C
    PLoS One; 2017; 12(4):e0175316. PubMed ID: 28445538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.
    Gates TM; Cysique LA
    CNS Drugs; 2016 Jan; 30(1):53-69. PubMed ID: 26749584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized mouse models for HIV-1 infection of the CNS.
    Honeycutt JB; Sheridan PA; Matsushima GK; Garcia JV
    J Neurovirol; 2015 Jun; 21(3):301-9. PubMed ID: 25366661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Complications in Controlled HIV Infection.
    Crossley KM; Brew BJ
    Curr Infect Dis Rep; 2013 Dec; 15(6):564-8. PubMed ID: 24142841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.
    Marcotte TD; Deutsch R; Michael BD; Franklin D; Cookson DR; Bharti AR; Grant I; Letendre SL;
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1123-35. PubMed ID: 24101401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and pathologic insights from latent HIV-1 infection in the human brain.
    Desplats P; Dumaop W; Smith D; Adame A; Everall I; Letendre S; Ellis R; Cherner M; Grant I; Masliah E
    Neurology; 2013 Apr; 80(15):1415-23. PubMed ID: 23486877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.
    Holman AG; Gabuzda D
    PLoS One; 2012; 7(11):e49538. PubMed ID: 23166702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.
    Williams DW; Eugenin EA; Calderon TM; Berman JW
    J Leukoc Biol; 2012 Mar; 91(3):401-15. PubMed ID: 22227964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive impact of antiretroviral treatment: thinking long-term.
    McPhail ME; Robertson KR
    Curr HIV/AIDS Rep; 2011 Dec; 8(4):249-56. PubMed ID: 21837444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regarding "Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors".
    Biscione FM
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):510; author reply 510-2. PubMed ID: 17993860
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.
    Robertson K; Jiang H; Kumwenda J; Supparatpinyo K; Evans S; Campbell TB; Price R; Tripathy S; Kumarasamy N; La Rosa A; Santos B; ; Silva MT; Montano S; Kanyama C; Faesen S; Murphy R; Hall C; Marra CM; Marcus C; Berzins B; Allen R; Housseinipour M; Amod F; Sanne I; Hakim J; Walawander A; Nair A;
    Clin Infect Dis; 2012 Sep; 55(6):868-76. PubMed ID: 22661489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.
    Cysique LA; Brew BJ
    Neuropsychol Rev; 2009 Jun; 19(2):169-85. PubMed ID: 19424802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive dysfunction in the highly active antiretroviral therapy era.
    Mothobi NZ; Brew BJ
    Curr Opin Infect Dis; 2012 Feb; 25(1):4-9. PubMed ID: 22156897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
    Vassallo M; Durant J; Biscay V; Lebrun-Frenay C; Dunais B; Laffon M; Harvey-Langton A; Cottalorda J; Ticchioni M; Carsenti H; Pradier C; Dellamonica P
    AIDS; 2014 Feb; 28(4):493-501. PubMed ID: 24472743
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.